Capital Breast Care Center Honored at British Embassy Event
October 13, 2010
On October 4, 2010, Sir Nigel Sheinwald, British Ambassador to the United States, hosted the Capital Breast Cancer Center at the British Embassy to honor the fight against breast cancer here and abroad. The reception recognized the Center’s efforts to provide comprehensive, culturally appropriate breast cancer screening services to DC area women and to promote health and wellness to women, regardless of their ability to pay.
"The CBCC performs an invaluable service to the Washington, DC community with screening services, educational outreach and patient support, without regard to income. And CBCC is fortunate to have Michelle Fenty as its most prominent advocate."
CBCC's Advisory Board President and Washington, DC's First Lady, Michelle Cross Fenty, told guests about the importance of CBCC's work. Each month, the CBCC provides breast cancer screening and critical prevention information to more than 200 medically underserved women in the Washington, DC area.
DC Mayor Adrian Fenty read a proclamation making October Breast Cancer Awareness Month in the District of Columbia and charged everyone with the role of helping people understand this deadly disease and working together to find a cure.
V. Craig Jordan, OBE, scientific director and vice chairman of oncology at the Georgetown Lombardi Comprehensive Cancer Center was recognized at the event for his contributions to the fight against breast cancer and praised as an example of the transatlantic relationship between the US and the UK. Born in Texas to a Bristish mother and American father, Jordan was the first to discover the breast cancer prevention properties of Tamoxifen, which has been used to treat millions of patients, and has saved more than half a million women with breast cancer.
In the United States, more than 270,000 women will be diagnosed with breast cancer in 2010 and more than 40,000 women will die from the disease. In Great Britain, breast cancer is the most common cancer; with more than 125 women diagnosed each day and more than 12,000 who will die this year.